RSS feed

Publications by Silja Skogstad Tuv

18 publications found

Original articles

Tuv SS, Bergh MS, Andersen JM, Steinsland S, Vindenes V, Baumann MH, Huestis MA, Bogen IL (2021)
Comparative Neuropharmacology and Pharmacokinetics of Methamphetamine and Its Thiophene Analog Methiopropamine in Rodents
Int J Mol Sci, 22 (21)
DOI 10.3390/ijms222112002, PubMed 34769427

Tuv SS, Bjånes TK, Nordal K (2020)
[Genotyping may result in fewer adverse effects in cancer therapy]
Tidsskr Nor Laegeforen, 140 (15)
DOI 10.4045/tidsskr.20.0628, PubMed 33118777

Tuv SS, Nordal K, Vethe NT, Bergan S (2019)
Pharmacogenetics in personalised drug therapy
Tidsskr Nor Laegeforen, 139 (8)
DOI 10.4045/tidsskr.19.0055, PubMed 31062549

Haga C, Opdal MS, Tuv SS, Zahl PH, Stenberg-Nilsen H (2016)
[Drug safety associated with the change of digitalis drug in Norway]
Tidsskr Nor Laegeforen, 136 (20), 1714-1718
DOI 10.4045/tidsskr.15.0161, PubMed 27830905

Høiseth G, Tuv SS, Karinen R (2016)
Blood concentrations of new designer benzodiazepines in forensic cases
Forensic Sci Int, 268, 35-38
DOI 10.1016/j.forsciint.2016.09.006, PubMed 27685473

Krabseth HM, Tuv SS, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Oiestad EL, Vindenes V (2016)
New psychoactive substances
Tidsskr. Nor. Laegeforen., 136 (8), 714-717

Tuv SS, Krabseth HM, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Oiestad EL, Vindenes V (2016)
New drugs right from the online
Tidsskr. Nor. Laegeforen., 136 (8), 721-723

Tuv SS, Krabseth HM, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Øiestad EL, Vindenes V (2016)
New designer drugs from the web
Tidsskr Nor Laegeforen, 136 (8), 721-3
DOI 10.4045/tidsskr.15.1276, PubMed 27143463

Tuv SS, Bergh MS, Vindenes V, Karinen R (2015)
Methiopropamine in blood samples from drivers suspected of being under the influence of drugs
Traffic Inj Prev, 17 (1), 1-4
DOI 10.1080/15389588.2015.1036157, PubMed 25874580

Karinen R, Tuv SS, Øiestad EL, Vindenes V (2014)
Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids
Forensic Sci Int, 246, 98-103
DOI 10.1016/j.forsciint.2014.11.012, PubMed 25485949

Karinen R, Tuv SS, Rogde S, Peres MD, Johansen U, Frost J, Vindenes V, Øiestad ÅM (2014)
Lethal poisonings with AH-7921 in combination with other substances
Forensic Sci Int, 244, e21-4
DOI 10.1016/j.forsciint.2014.08.013, PubMed 25216892

Tuv SS, Krabseth H, Karinen R, Olsen KM, Øiestad EL, Vindenes V (2013)
Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period
Accid Anal Prev, 62, 26-31
DOI 10.1016/j.aap.2013.09.009, PubMed 24129318

Review articles

Krabseth HM, Tuv SS, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Øiestad EL, Vindenes V (2016)
Novel psychoactive substances
Tidsskr Nor Laegeforen, 136 (8), 714-7
DOI 10.4045/tidsskr.15.1278, PubMed 27143461

Bretteville-Jensen AL, Tuv SS, Bilgrei OR, Fjeld B, Bachs L (2013)
Synthetic Cannabinoids and Cathinones: Prevalence and Markets
Forensic Sci Rev, 25 (1-2), 7-26
PubMed 26226848

Tuv SS, Strand MC, Karinen R, Øiestad EL, Christophersen AS, Vindenes V (2012)
[Effect and occurrence of synthetic cannabinoids]
Tidsskr Nor Laegeforen, 132 (20), 2285-8
DOI 10.4045/tidsskr.12.0471, PubMed 23736196

Other articles

Tuv SS, Spigset O, Jensen E, Vethe NT, Nordal K (2023)
[Not Available]
Tidsskr Nor Laegeforen, 143 (13)
DOI 10.4045/tidsskr.23.0496, PubMed 37753760

Tuv SS, Bjanes TK, Nordal K (2020)
Genotyping may cause fewer side effects with cancer treatment
Tidsskr. Nor. Laegeforen., 140 (15), 1530

Tuv SS, Vethe NT, Bergan S, Nordal K (2019)
Pharmacogenetics in personalised drug therapy
Tidsskr. Nor. Laegeforen., 139 (8), 700-702